Showing results (11-20 of 287) with videos related to
Sort By:
Pageof 29
Annals of the New York Academy of Sciences|April 25, 2015
mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and agingAndras PerlCurrent Opinion in Rheumatology|July 9, 2009
Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndromeAndras PerlMethods in Molecular Biology (Clifton, N.J.)|August 31, 2012
Pathogenesis and spectrum of autoimmunityAndras PerlArthritis & Rheumatology (Hoboken, N.J.)|November 22, 2017
Blockade of Treg Cell Differentiation and Function by the Interleukin-21-Mechanistic Target of Rapamycin Axis Via Suppression of Autophagy in Patients With Systemic Lupus ErythematosusHiroshi Kato, Andras PerlMethods in Molecular Medicine|August 3, 2004
Evaluation of autoimmunity to transaldolase in multiple sclerosisBrian Niland, Andras PerlInternational Journal of Clinical Rheumatology|March 9, 2010
Infection in systemic lupus erythematosus: friend or foe?Lisa Francis, Andras PerlReactive Oxygen Species (Apex, N.C.)|May 29, 2018
Measurement of Mitochondrial Mass by Flow Cytometry during Oxidative StressEdward Doherty, Andras PerlImmunometabolism (Cobham, Surrey)|October 31, 2022
Principles behind SLE treatment with <i>N</i>-acetylcysteineSandy Nasr, Andras PerlAutoimmunity Reviews|October 31, 2021
Therapeutic mTOR blockade in systemic autoimmunity: Implications for antiviral immunity and extension of lifespanChristian Geier, Andras PerlMethods in Molecular Biology (Clifton, N.J.)|August 31, 2012
The role of endocytic recycling in autoimmunityTiffany Telarico, Andras PerlPageof 29